Molecular Cloning of Monkey Histamine H4 Receptor
スポンサーリンク
概要
- 論文の詳細を見る
Histamine H4 receptor is considered as a novel therapeutic target for allergic diseases. To enhance the knowledge about species difference, which is essential for drug discovery research, monkey H4 receptor was identified. Monkey H4 receptor was characterized to have comparable similarity with its human counterpart. Discovery of monkey H4 receptor will contribute to a better interpretation of effective drug discovery.
- 社団法人 日本薬理学会の論文
著者
-
Matsumoto Shun-ichiro
Molecular Medicine Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Takasaki Jun
Molecular Medicine Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Matsumoto Mitsuyuki
Molecular Medicine Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Kobori Masato
Molecular Medicine Laboratories Astellas Pharma Co. Ltd.
-
Katoh Masao
Molecular Medicine Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
ODA Tamaki
Molecular Medicine Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
KAMOHARA Masazumi
Molecular Medicine Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
SOGA Takatoshi
Molecular Medicine Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
HIYAMA Hideki
Molecular Medicine Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
-
Kamohara Masazumi
Molecular Medicine Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Hiyama Hideki
Molecular Medicine Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Oda Tamaki
Molecular Medicine Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Soga Takatoshi
Molecular Medicine Laboratories Yamanouchi Pharmaceutical Co. Ltd.
-
Takasaki Jun
Molecular Medicine Laboratories, Yamanouchi Pharmaceutical Co., Ltd.
関連論文
- 2P-282 抗体カノニカル構造再訪(生命情報科学・構造ゲノミクス,第46回日本生物物理学会年会)
- Molecular Cloning of Monkey Histamine H_4 Receptor
- Molecular Cloning of Monkey Histamine H4 Receptor
- Involvement of G_ in both integrin signal-dependent and -independent pathways regulating endothelin-induced neural progenitor proliferation
- Thrombolysis with Intracoronary Administration of YM866, a Novel Modified Tissue-Type Plasminogen Activator, in a Canine Model of Coronary Artery Thrombosis.